07.10.2016
- Israel’s Teva Pharmaceutical Industries is planning to sell the assets of Actavis Generics in the UK and Ireland to Accord Healthcare, a subsidiary of India’s Intas Pharmaceuticals...
02.09.2016
- During the last two decades the pharmaceutical industry was forced to undertake significant structural changes to address mounting challenges from strict regulatory policies, lower...
09.08.2016
- Israel’s Teva Pharmaceutical Industries has agreed to buy Allergan’s generics distributer Anda for $500 million. Anda distributes generic, branded, specialty and over-the-counter...
29.07.2016
- Israel’s Teva Pharmaceutical Industries has been cleared by the US Federal Trade Commission (FTC) to proceed with its purchase of Allergan’s generics business after agreeing to...
12.05.2016
- The good old days are gone — at least with regard to simplicity in business life. This is particularly true for life sciences companies affected by trends increasing the complexity...
11.05.2016
- Israel-based Teva, the world's largest generic drugmaker, still expects its $40.5 billion acquisition of Allergan's generics business, which trades as Actavis, to close in June...
07.04.2016
- The targeted $160 billion merger between Pfizer and Allergan has run afoul of new anti-inversion legislation proposed by the US Treasury, as had been predicted by most deal...
04.04.2016
- Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...
